NCT04549493

Brief Summary

The purpose of this requirement is to identify an effective exposure psychotherapy paradigm for the treatment of Post-Traumatic Stress Disorder (PTSD) in active duty service members and veterans by comparing different exposure psychotherapy modalities. The long-term goal of exposure psychotherapy is to improve the mental health of U.S. service members and veterans with military-related PTSD. Recovery from PTSD will reduce the economic burden not only for those persons experiencing PTSD, but also for the health care system and society as a whole (Galovski \& Lyons, 2004).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
134

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 12, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 22, 2020

Completed
4 months until next milestone

First Posted

Study publicly available on registry

September 16, 2020

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2024

Completed
Last Updated

May 10, 2024

Status Verified

December 1, 2023

Enrollment Period

3.9 years

First QC Date

May 22, 2020

Last Update Submit

May 9, 2024

Conditions

Keywords

Trauma Management TherapyExposure TherapyGroup TherapyPTSDMilitary

Outcome Measures

Primary Outcomes (3)

  • Change from Baseline on the Clinician-Administered PTSD Scale for DSM-5

    PTSD symptoms rating scale (severity and frequency) administered by blinded clinician

    1 week posttreatment

  • Change from Baseline on the Clinician-Administered PTSD Scale for DSM-5

    PTSD symptoms rating scale (severity and frequency) administered by blinded clinician

    3 months posttreatment

  • Change from Baseline on the Clinician-Administered PTSD Scale for DSM-5

    PTSD symptoms rating scale (severity and frequency) administered by blinded clinician

    6 months posttreatment

Secondary Outcomes (48)

  • Change from Baseline on the Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5)

    1 week posttreatment

  • Change from Baseline on the Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5)

    3 months posttreatment

  • Change from Baseline on the Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5)

    6 months posttreatment

  • Change from Baseline on the Traumatic Life Events Questionnaire (TLEQ)

    1 week posttreatment

  • Change from Baseline on the Traumatic Life Events Questionnaire (TLEQ)

    3 months posttreatment

  • +43 more secondary outcomes

Study Arms (3)

Trauma Management Therapy

ACTIVE COMPARATOR

1\. Trauma Management Therapy (TMT; Turner, Beidel, \& Frueh, 2005): TMT is a multicomponent behavioral treatment program designed to target various aspects of chronic PTSD - reducing emotional and physiological reactivity to traumatic cues, reducing intrusive symptoms and avoidance behavior, improving interpersonal skills and emotion modulation (e.g., anger control), and increasing the range of enjoyable social activities. In this investigation and in line with our previous publications, TMT will include virtual-reality augmented exposure (i.e. olfactory stimulation, heart rate, and skin conductance); group therapy to address sleep, anger, depression, and social isolation; homework assignments; and programmed practice. In the 3-week treatment program, each participant receives virtual-reality assisted exposure in the morning followed by in vivo exposure and group therapy (SER) each afternoon for a total of 29 sessions.

Behavioral: Exposure Therapy

Prolonged Exposure

ACTIVE COMPARATOR

2\. Standard Prolonged Exposure (PE; Foa, Hembree, \& Rothbaum, 2007) consists of psychoeducation, imaginal exposure to trauma memories, in vivo exposure to situations that are avoided due to their association with the trauma, and emotional processing. The standard protocol consists of 12 imaginal exposure sessions, along with in vivo exposure/homework assignments and listening to a recording of the imaginal sessions at home during the evening.

Behavioral: Exposure Therapy

Compressed Prolonged Exposure

ACTIVE COMPARATOR

3\. Compressed PE consists of 10 standard PE sessions delivered on consecutive work days. The imaginal exposure sessions take place in the morning, with in vivo exposures assigned (not therapist accompanied) for the afternoons. Patients are instructed to listen to the recordings of the imaginal exposure each night. Being most concerned with having enough time for in vivo practice, Session 1 does not start on a Monday, allowing for two full weekends in order to maximize in vivo exposures. Both versions of PE average 36 total treatment hours.

Behavioral: Exposure Therapy

Interventions

Exposure Therapy is used to reduce the symptoms of PTSD

Compressed Prolonged ExposureProlonged ExposureTrauma Management Therapy

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Active duty military personnel with a diagnoses of PTSD
  • Traumatic event must have occurred during military service
  • Military sexual trauma limited to attempted or completed sexual assault.

You may not qualify if:

  • Acute cardiac difficulties
  • Severe comorbid substance use disorders.
  • Diagnosis of schizophrenia or other psychotic disorders
  • Diagnosis of antisocial personality disorder
  • Moderate or severe traumatic brain injury (TBI)
  • Use of benzodiazepines

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCF RESTORES, University of Central Florida

Orlando, Florida, 32816, United States

Location

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Interventions

Implosive Therapy

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Desensitization, PsychologicBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Deborah Beidel, Ph.D.

    University of Central Florida

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 22, 2020

First Posted

September 16, 2020

Study Start

February 12, 2020

Primary Completion

December 20, 2023

Study Completion

May 1, 2024

Last Updated

May 10, 2024

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations